Results 91 to 100 of about 13,725 (110)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Follow the trail: Using insights from the growth of palliative care to propose a roadmap for cancer rehabilitation

Ca-A Cancer Journal for Clinicians, 2019
Timothy F Marshall, Joseph Andrew Greer, Julie K Silver   +2 more
exaly  

Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma

Cancer Cell, 2014
Robert J Vanner, Marc Remke, Marco Gallo
exaly  

Economic Growth and the Elasticity of Substitution: Two Theorems and Some Suggestions

American Economic Review, 2000
Rainer Klump
exaly  

Subgroup analysis and other (mis)uses of baseline data in clinical trials

Lancet, The, 2000
Stuart J Pocock
exaly  

Subgroup analysis in randomised controlled trials: importance, indications, and interpretation

Lancet, The, 2005
Peter M Rothwell
exaly  

Hematopoietic growth factors

Ca-A Cancer Journal for Clinicians, 1996
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

The National Cancer Data Base: ten years of growth and commitment

Ca-A Cancer Journal for Clinicians, 1998
exaly  

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

Lancet, The, 2009
Bartolome Celli, Steven Kesten, Donald P Tashkin   +2 more
exaly